Evolent Health (EVH) Accumulated Expenses (2015 - 2026)

Evolent Health's Accumulated Expenses history runs 12 years deep, the most recent figure standing at $45.1 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 54.72% year-over-year to $45.1 million in Q1 2026; TTM through Mar 2026 was $45.1 million, a 54.72% decrease from a year earlier, with the FY2025 full-year figure at $65.8 million, up 95.01% from the prior year.
• Accumulated Expenses slipped to $45.1 million in Q1 2026 per EVH's latest filing, from $65.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $194.0 million in Q3 2023 and bottomed at $27.5 million in Q1 2023.
• The 5-year median for Accumulated Expenses is $65.8 million (2025), against an average of $85.7 million.
• Biggest YoY gain for Accumulated Expenses was 499.77% in 2024; the steepest drop was 77.5% in 2024.
• Year by year, Accumulated Expenses stood at $111.2 million in 2022, then soared by 34.76% to $149.8 million in 2023, then plunged by 77.5% to $33.7 million in 2024, then surged by 95.01% to $65.8 million in 2025, then tumbled by 31.47% to $45.1 million in 2026.
• Per Business Quant, the three latest EVH Accumulated Expenses figures stand at $45.1 million (Q1 2026), $65.8 million (Q4 2025), and $60.9 million (Q3 2025).